Chlophedianol
As of the edition of 20 October 2026, Chlophedianol is a small molecule: marketed, first approved in 1962 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Ulo
- First approved
- 31 December 1962 (CA)
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- 3M; 2 holders in all
- Registered trials
- 2, 0 stopped early
- Disease areas
- Immune system; Infections; Urinary and reproductive
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 1 | 0 | 1 | 0 |
| Phase 3 | 1 | 0 | 1 | 0 |
| All trials | 2 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Bausch Health | Applicant | 1962 to now |
| 3M | Applicant and Later holder |